4basebio
4basebio provides innovative technologies and products for gene therapy and vaccine development. Our enzymatic DNA synthesis platform allows for the GMP production of DNA products at unparalleled speed, scale, and purity as compared to pDNA. The proprietary DNA products feed into the production of mRNA, viral vectors and DNA vaccine technologies. 4basebio’s targeted, non-viral delivery platform, Hermes™, allows targeting towards specific cells or tissues of interest, and is suitable for a range of nucleic acid and biological payloads. Together, these platform technologies can greatly accelerate the development of gene therapy and vaccine programmes.Content by 4basebio
| 2 min read
Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market
| 4 min read
Synthetic DNA is increasingly used for gene therapies due to its fast production and improved scalability compared to traditional plasmid-based methods.
Page 1 of 1 - 2 Total Items
